BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23534780)

  • 1. EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line.
    Najar AG; Pashaei-Asl R; Omidi Y; Farajnia S; Nourazarian AR
    Asian Pac J Cancer Prev; 2013; 14(1):495-8. PubMed ID: 23534780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined EGFR and c-Src antisense oligodeoxynucleotides encapsulated with PAMAM Denderimers inhibit HT-29 colon cancer cell proliferation.
    Nourazarian AR; Najar AG; Farajnia S; Khosroushahi AY; Pashaei-Asl R; Omidi Y
    Asian Pac J Cancer Prev; 2012; 13(9):4751-6. PubMed ID: 23167414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Src antisense complexed with PAMAM denderimes decreases of c-Src expression and EGFR-dependent downstream genes in the human HT-29 colon cancer cell line.
    Nourazarian AR; Pashaei-Asl R; Omidi Y; Najar AG
    Asian Pac J Cancer Prev; 2012; 13(5):2235-40. PubMed ID: 22901200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
    Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
    Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells.
    Nakhlband A; Barar J; Bidmeshkipour A; Heidari HR; Omidi Y
    J Biomed Nanotechnol; 2010 Aug; 6(4):360-9. PubMed ID: 21323109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
    Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
    Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells.
    Ping Y; Jian Z; Yi Z; Huoyu Z; Feng L; Yuqiong Y; Shixi L
    Med Oncol; 2010 Sep; 27(3):715-21. PubMed ID: 19653138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides to the epidermal growth factor receptor.
    Witters L; Kumar R; Mandal M; Bennett CF; Miraglia L; Lipton A
    Breast Cancer Res Treat; 1999 Jan; 53(1):41-50. PubMed ID: 10206071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
    Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P
    Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
    Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines.
    Rubenstein M; Slobodskoy L; Mirochnik Y; Guinan P
    Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):649-52. PubMed ID: 12616956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
    He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
    J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composites of Nucleic Acids and Boron Clusters (C
    Kaniowski D; Ebenryter-Olbińska K; Kulik K; Suwara J; Cypryk W; Jakóbik-Kolon A; Leśnikowski Z; Nawrot B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
    Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G
    Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.
    Friday E; Oliver R; Welbourne T; Turturro F
    Cell Physiol Biochem; 2007; 20(6):751-62. PubMed ID: 17982257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O; Hacker NF; Cho-Chung YS
    Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
    Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated delivery of an antisense gene to human brain cancer cells.
    Zhang Y; Jeong Lee H; Boado RJ; Pardridge WM
    J Gene Med; 2002; 4(2):183-94. PubMed ID: 11933219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.